Blog
Practical guides based on 6 years of endorsement coaching and 200+ rejection proformas analysed.
Over 100 commercial R&D companies including AstraZeneca, JLR, Arm and GSK have been added to the UKRI approved list. What changed, who qualifies, and what to do if you do not.
What I observe in practice that does not appear in the published Notion guide, and why the gap matters.
The research route is for researchers, not doctors. What the mandatory requirements actually are, and who from a medical background qualifies.
The most important document in the peer review portfolio, and the one most likely to be written in the wrong way.
Talent only, mandatory award criteria, exact timeframes. What film and TV professionals need to know.
Quality wins over quantity. What the spectrum of exhibitions means for your portfolio and what assessors flag.
The CV is the most common rejection reason on the arts route. Here is how to write one that works.
The most common rejection reasons across mandatory criteria, reference letters, evidence formatting and OC1 to OC4.
Interior, urban, jewellery and more: where the line sits and which body assesses your work.
A new Design route launched on 1 July 2026, assessed by the Design Business Association. Who qualifies and how it works.
The most common rejection reasons on the arts route. Real feedback from real assessors.
All three stages, including the preparation stage most guides skip.
Every fee for 2026: endorsement, visa, health surcharge and ILR, with worked examples.
The four essential eligibility steps before you start building a portfolio.
The most common concern on the research route. More fixable than you think.
The single most common mistake in arts applications. A review is not a listing.
What founders actually need to demonstrate, what typically fails, and how the criteria fit together.
Eligibility, evidence, referees and the most common rejection reasons.